EXTRINSIC PATHWAY INHIBITOR (EPI) IN TISSUE FACTOR (TF) INDUCED INTRAVASCULAR COAGULATION IN RABBITS

被引：0
|
作者：
WARR, TA
RAO, LVM
RAPAPORT, SI
机构：
[1] UNIV CALIF SAN DIEGO,DEPT MED,SAN DIEGO,CA 92103
[2] UNIV CALIF SAN DIEGO,DEPT PATHOL,SAN DIEGO,CA 92103
来源：
CLINICAL RESEARCH | 1989年 / 37卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：A156 / A156
页数：1
相关论文
共 50 条
  • [31] Extrinsic coagulation factors and tissue factor pathway inhibitor in end-stage chronic renal failure
    Matsuo, T
    Koide, M
    Kario, K
    Suzuki, S
    Matsuo, M
    HAEMOSTASIS, 1997, 27 (04) : 163 - 167
  • [32] The extrinsic coagulation cascade and tissue factor pathway inhibitor in macrophages: A potential therapeutic opportunity for atherosclerotic thrombosis
    Jiang, Pengfei
    Xue, Dong
    Zhang, Yingjia
    Ye, Longwu
    Liu, Yuan
    Makale, Milan
    Kesari, Santosh
    Edgington, Thomas S.
    Liu, Cheng
    THROMBOSIS RESEARCH, 2014, 133 (04) : 657 - 666
  • [33] Tissue factor (TF) and tissue factor pathway inhibitor (TFPI) on the blood of DVT patients
    Ojiro, M
    Yamazumi, K
    Takenoshita, M
    Aikou, T
    CURRENT TOPICS IN PHLEBOLOGY, 1997, : 183 - 187
  • [34] Tissue factor pathway inhibitor response does not correlate with tissue factor-induced disseminated intravascular coagulation and multiple organ dysfunction syndrome in trauma patients
    Gando, S
    Nanzaki, S
    Morimoto, Y
    Ishitani, T
    Kemmotsu, O
    CRITICAL CARE MEDICINE, 2001, 29 (02) : 262 - 266
  • [35] Changes in plasma tissue factor pathway inhibitor levels during the clinical course of disseminated intravascular coagulation
    Yamamuro, M
    Wada, H
    Kumeda, K
    Inoue, A
    Tsuji, I
    Nakasaki, T
    Shimura, M
    Hiyoyama, K
    Gabazza, EC
    Nishikawa, M
    Deguchi, K
    Shiku, H
    Kato, H
    BLOOD COAGULATION & FIBRINOLYSIS, 1998, 9 (06) : 491 - 497
  • [36] Increased truncated form of plasma tissue factor pathway inhibitor levels in patients with disseminated intravascular coagulation
    Shimura, M
    Wada, H
    Nakasaki, T
    Hiyoyama, K
    Mori, Y
    Nishikawa, M
    Deguchi, H
    Deguchi, K
    Gabazza, EC
    Shiku, H
    AMERICAN JOURNAL OF HEMATOLOGY, 1999, 60 (02) : 94 - 98
  • [37] TISSUE FACTOR AND THE EXTRINSIC PATHWAY OF COAGULATION DURING INFECTION AND VASCULAR INFLAMMATION
    CARSON, SD
    JOHNSON, DR
    TRACY, SM
    EUROPEAN HEART JOURNAL, 1993, 14 : 98 - 104
  • [38] TISSUE FACTOR PATHWAY INHIBITOR AND THE REVISED THEORY OF COAGULATION
    BROZE, GJ
    ANNUAL REVIEW OF MEDICINE, 1995, 46 : 103 - 112
  • [39] EXTRINSIC PATHWAY INHIBITOR IN DISSEMINATED INTRAVASCULAR COAGULATION AND SEVERE ACUTE AND CHRONIC LIVER-DISEASE
    WARR, TA
    RAO, VM
    RAPAPORT, SI
    ARTERIOSCLEROSIS, 1988, 8 (05): : A666 - A666
  • [40] Antithrombotic effect of human recombinant tissue factor pathway inhibitor on endotoxin-induced intravascular coagulation in rats: Concerted effect with antithrombin
    Kamikubo, Y
    Hamuro, T
    Matsuda, J
    Shinya, N
    Miyamoto, S
    Funatsu, A
    Kato, H
    THROMBOSIS AND HAEMOSTASIS, 1996, 76 (04) : 621 - 626
12345